TCF7 and hepatitis C virus infection: In addition, TCF1 is currently being investigated as a potential clinical biomarker for assessing the efficacy of immunotherapy or viral control in HIV and hepatitis C treatment (16, 19), suggesting TCF1 as potential clinical biomarker in the future.